Oxytocin and Borderline Personality Disorder
Borderline personality disorder (BPD) is a prevalent and severe mental disorder with affect dysregulation, impulsivity, and interpersonal dysfunction as its core features. Up to now, six studies have been performed to investigate the role of oxytocin in the pathogenesis of BPD. While a beneficial ef...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Kapitel/Artikel |
| Sprache: | Englisch |
| Veröffentlicht: |
16 August 2017
|
| In: |
Behavioral pharmacology of neuropeptides: Oxytocin
Year: 2017, Pages: 499-514 |
| DOI: | 10.1007/7854_2017_26 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/7854_2017_26 Verlag, Volltext: https://link.springer.com/chapter/10.1007/7854_2017_26 |
| Verfasserangaben: | Katja Bertsch, Sabine C. Herpertz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576086437 | ||
| 003 | DE-627 | ||
| 005 | 20230523085635.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180606s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/7854_2017_26 |2 doi | |
| 035 | |a (DE-627)1576086437 | ||
| 035 | |a (DE-576)506086437 | ||
| 035 | |a (DE-599)BSZ506086437 | ||
| 035 | |a (OCoLC)1341010890 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bertsch, Katja |d 1981- |e VerfasserIn |0 (DE-588)141519568 |0 (DE-627)629442355 |0 (DE-576)324253478 |4 aut | |
| 245 | 1 | 0 | |a Oxytocin and Borderline Personality Disorder |c Katja Bertsch, Sabine C. Herpertz |
| 264 | 1 | |c 16 August 2017 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.06.2018 | ||
| 520 | |a Borderline personality disorder (BPD) is a prevalent and severe mental disorder with affect dysregulation, impulsivity, and interpersonal dysfunction as its core features. Up to now, six studies have been performed to investigate the role of oxytocin in the pathogenesis of BPD. While a beneficial effect of oxytocin on threat processing and stress responsiveness was found, other studies using an oxytocin challenge design presented with rather heterogeneous results. Future studies have to include a sufficiently large sample of patients, control for gender, and focus on mechanisms known to be related to aversive early life experiences. | ||
| 700 | 1 | |a Herpertz, Sabine |d 1960- |e VerfasserIn |0 (DE-588)132328526 |0 (DE-627)520581113 |0 (DE-576)182985261 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Behavioral pharmacology of neuropeptides: Oxytocin |d Cham : Springer International Publishing, 2018 |g (2017), Seite 499-514 |h Online-Ressource (IX, 593 Seiten) |w (DE-627)1028028563 |w (DE-576)508127351 |z 9783319637396 |7 nnam |a Oxytocin and Borderline Personality Disorder |
| 773 | 1 | 8 | |g year:2017 |g pages:499-514 |g extent:16 |a Oxytocin and Borderline Personality Disorder |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/7854_2017_26 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/chapter/10.1007/7854_2017_26 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180606 | ||
| 993 | |a BookComponentPart | ||
| 994 | |a 2017 | ||
| 998 | |g 132328526 |a Herpertz, Sabine |m 132328526:Herpertz, Sabine |d 910000 |d 910600 |e 910000PH132328526 |e 910600PH132328526 |k 0/910000/ |k 1/910000/910600/ |p 2 |y j | ||
| 998 | |g 141519568 |a Bertsch, Katja |m 141519568:Bertsch, Katja |d 910000 |d 910600 |d 100000 |e 910000PB141519568 |e 910600PB141519568 |e 100000PB141519568 |k 0/910000/ |k 1/910000/910600/ |k 0/100000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1576086437 |e 3011736944 | ||
| BIB | |a Y | ||
| JSO | |a {"name":{"displayForm":["Katja Bertsch, Sabine C. Herpertz"]},"id":{"eki":["1576086437"],"doi":["10.1007/7854_2017_26"]},"physDesc":[{"extent":"16 S."}],"recId":"1576086437","origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"16 August 2017"}],"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"edited-book"},"title":[{"title_sort":"Behavioral pharmacology of neuropeptides: Oxytocin","title":"Behavioral pharmacology of neuropeptides: Oxytocin"}],"origin":[{"publisher":"Springer International Publishing","dateIssuedDisp":"2018","publisherPlace":"Cham","dateIssuedKey":"2018"}],"person":[{"family":"Hurlemann","role":"edt","given":"René","display":"Hurlemann, René"},{"given":"Valéry","role":"edt","family":"Grinevich","display":"Grinevich, Valéry"}],"disp":"Oxytocin and Borderline Personality DisorderBehavioral pharmacology of neuropeptides: Oxytocin","physDesc":[{"extent":"Online-Ressource (IX, 593 Seiten)"}],"relMultPart":[{"recId":"870271490","dispAlt":"Current topics in behavioral neurosciences","disp":"Current Topics in Behavioral Neurosciences","origin":[{"dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisherPlace":"Heidelberg [u.a.]","publisher":"Springer"}],"pubHistory":["Nachgewiesen 18.2014 -"],"id":{"zdb":["2871405-2"],"eki":["870271490"]},"part":{"number_sort":["35"],"number":["volume 35"]},"title":[{"title":"Current topics in behavioral neurosciences","title_sort":"Current topics in behavioral neurosciences"}],"type":{"media":"Online-Ressource","bibl":"serial"},"language":["eng"]}],"recId":"1028028563","id":{"eki":["1028028563"],"isbn":["9783319637396"],"doi":["10.1007/978-3-319-63739-6"]},"part":{"extent":"16","text":"(2017), Seite 499-514","year":"2017","pages":"499-514"},"name":{"displayForm":["Rene Hurlemann, Valery Grinevich, editors"]}}],"person":[{"display":"Bertsch, Katja","family":"Bertsch","given":"Katja","role":"aut"},{"display":"Herpertz, Sabine","family":"Herpertz","role":"aut","given":"Sabine"}],"type":{"media":"Online-Ressource","bibl":"chapter"},"language":["eng"],"note":["Gesehen am 06.06.2018"],"title":[{"title":"Oxytocin and Borderline Personality Disorder","title_sort":"Oxytocin and Borderline Personality Disorder"}]} | ||
| SRT | |a BERTSCHKATOXYTOCINAN1620 | ||